| Theres exciting news for people with von Hippel-Lindau (VHL) disease, a rare genetic disorder that can lead to cancerous and non-cancerous tumors in multiple organs, including the brain, spinal cord, kidney, and pancreas. In August 2021, the FDA approved belzutifan (Welireg), a new drug that has been shown in a... Read More . . . | 